Teaser - Drug Reserach Scenario in India (v 0.99)

…………. Realizing Possibilities

Research Report on Drug Discovery Scenario in India

INTRODUCTION

Common perception about Indian Pharma companies is that they are good in The research report of Aagami - ‘Drug Scenario
generics and that drug discovery activities are less in India. in India’ – reveals how and what Indian
Contrarian to popular belief, it was in the late 1990’s, that Indian Pharma companies are doing in the area of drug
companies started in-house drug discovery activities, aiming at developing the discovery and details out which companies are
country’s first home-made drug. most active in the area of drug discovery.
Today, there are many Indian companies involved in drug discovery. Even
Government is lending help and supporting research activities in a big way through A must read for global companies who wish to
IP Protection laws and Public Private Partnerships in this space. collaborate with Indian companies
New Drug Discovery has gained strong foothold in India.

India is today one of the most sought after destinations for
collaboration in drug Discovery

Copyright © 2012 Aagami, Inc - Research Report/Drug Discovery Scenario in India Page 1


Research Scope and Structure

Overview: Historical perspective of Trends in Drug
Current status in Drug Government Initiatives Conclusion
Indain Pharma Market Discovery
Discovery

 The Indian Pharma  Top Indian Pharma  Major therapeutic  India’s IP regime  Benefits of Collaboration
market prior to companies expenditure areas for drug
introduction of Patents on R&D. discovery
Act of 1970

 Presence of  Partnering with MNcs for  Major Platform  Public Private  Conclusion
Multinational Drug Discovery /CRO considered/focused for Partnership
companies NDDS
 Introduction of Patents  M&A  Biosimilars
Act of 1970

 Impact of TRIPS w.e.f  Paradigm shift  Repurposing
January 1995



Table of Contents:

1. Introduction
a. Objective of white paper
b. Executive Summary
2. Acronyms Used
3. Overview: Historical perspective of Indian Pharma market
a. Key Takeaway in Indian Pharma sector before and after enactment of Patents Act 1970
b. Table for three phases in Indian Pharmaceuticals.
c. Impact of TRIPS on Indian Pharmaceutical companies
4. Scenario in India after 1970 patent Law which recognized process patents
a. Example of Importance of India as the “Pharmacy for the developing world
5. Impact of World Trade Organization’s Trade Related Aspects of Intellectual Property Rights (TRIPs) agreement on India
6. Current Status: In-Licensing & Out Licensing Deal (2002- 2011)
a. Table for India’s top Pharmaceuticals company by sales and R&D expenditure
b. Key examples of Drug discovery collaboration
c. Table for R&D Out-Licensing deal.
d. Table for Collaborative R&D agreement
e. Table for Collaborative research done in India
f. Table for Out-Licensing in India with global partners
Contract Research (2006-2011)
g. Table for R&D service agreement by Indian companies with MNC partner
Mergers & Acquisitions (2004- 2012)
h. Other R&D deal.
i. Matrix for type of Alliances in India
7. Drug Portfolio pipeline of top Indian Pharma companies
8. Examples of Indian companies offering Drug Discovery service
9. Trends in Drug Discovery in India
a. Top therapy areas in focus
b. Table for Company & therapy areas



c. Biosimilars in India
d. Top pharma companies & their biosimilar portfolio
e. NDDS
f. NDDS success stories & Market segment
g. Repurposing of Drugs in India
h. Initiatives for Repurposing of Drugs

10. India’s IP regimes & Government Initiatives
11. Benefits Of Collaborations
12. Conclusion

Rest of Page is blank. SEE NEXT PAGE



Key Highlights of the report:
1. The report gives whole scenario of Drug Discovery activities being carried out in India
2. Current market scenario in India
3. Top Indian Pharma companies with sales and R&D expenditures
4. Information on M&A, Joint research, CRO deals , In-Licensing, Out- Licensing deals took place
5. Top Indian Pharma companies with Drug Portfolios, patent pipeline, NCE pipelines
6. Types of Alliances in India with MNCs.
7. Trends in Drug Discovery
8. Government Initiatives & India IP regime
9. Benefits of Collaborations
10. Facts and figures on India’s advantage for Drug discovery as compared to developed countries

A Must Buy for:
1. Foreign companies who wish to collaborate with Indian companies

2. Existing Pharma/Biotech/ Drug Discovery Firms: To know their Indian counterpart Drug Development pipeline, trends,
Information on leading pharma companies by sales & their R&D expenses.

3. New Pharma/Biotech/ Drug Discovery Firms: Information on In-Licensing & Out- Licensing scenario. Information on existing &
new players in Drug Discovery

4. Research & Educational Institutes: To get an overview of India’s pharma & drug discovery scenario and current trends in Drug
R&D

5. Consultants: To upgrade their knowledge in Indian pharma and drug R&D space.

6.


Sample Snapshots of the Report:

The Snapshots provided hereby is just a sneak peak of the
whole report.

The original document comprise of 34 slides. The report gives
a complete scenario about the research activities being
carried out in India.

India has proven conducive environment, infrastructure to
carry out their drug research work and as well assist global
pharmaceuticals and biotech firms in their research activities.




Contact us at godwyn@aagami.net or
Nidhi@aagami.net to have complete access
to the full details of the report



The Snapshots provided in previous pages, is just a sneak peak of the whole report.

The original document consists of 34 slides. The report gives a complete scenario about the research activities being carried out in
India.

India has proven conducive environment, infrastructure to carry out their drug research work and as well assist global
pharmaceuticals and biotech firms in their research activities.

To place an order for this report, please get in touch with:

Godwyn Francis - Head of Business Development, Aagami, Inc.

Email Id: godwyn@aagami.net

Contact number: +1- 630-780-5830

Aagami Inc,

2020 Calamos Court, Suite 209,
Naperville IL 60563-2593

www.aagami.net

Teaser - Drug Reserach Scenario in India (v 0.99)

Teaser - Drug Reserach Scenario in India (v 0.99)

Recommended

Recommended

More Related Content

More from Aagami, Inc.

More from Aagami, Inc. (18)

Recently uploaded

Recently uploaded (20)

Teaser - Drug Reserach Scenario in India (v 0.99)